芒果视频下载

衛(wei)(wei)材(cai)在華企業隸屬于衛(wei)(wei)材(cai)株式會社，衛(wei)(wei)材(cai)株式會社是一家以研究開發醫藥產(chan)品為(wei)主的(de)跨國公司(si)，總(zong)部設在日本東京。

衛(wei)(wei)材(cai)(cai)(cai)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)自上世紀90年代初進入中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)市場以(yi)來(lai)順(shun)利(li)發(fa)展(zhan)壯大。自1991年先后成(cheng)立沈陽(yang)衛(wei)(wei)材(cai)(cai)(cai)制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司和衛(wei)(wei)材(cai)(cai)(cai)（蘇州）制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司，并于2002年正(zheng)式(shi)更(geng)名為(wei)衛(wei)(wei)材(cai)(cai)(cai)（中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)）藥(yao)(yao)(yao)業(ye)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司。伴隨(sui)著中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)業(ye)務的發(fa)展(zhan)，于2010年成(cheng)立衛(wei)(wei)材(cai)(cai)(cai)（蘇州）貿易有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司，于2014年成(cheng)立衛(wei)(wei)材(cai)(cai)(cai)（中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)）投(tou)資(zi)(zi)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司，并于2015年通(tong)過全額收(shou)購本(ben)地(di)仿制(zhi)(zhi)藥(yao)(yao)(yao)企業(ye)正(zheng)式(shi)成(cheng)立衛(wei)(wei)材(cai)(cai)(cai)（遼寧(ning)）制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司。至此，形成(cheng)了以(yi)衛(wei)(wei)材(cai)(cai)(cai)（中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)）投(tou)資(zi)(zi)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司為(wei)資(zi)(zi)控管(guan)理，以(yi)衛(wei)(wei)材(cai)(cai)(cai)（中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)）藥(yao)(yao)(yao)業(ye)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司、衛(wei)(wei)材(cai)(cai)(cai)（遼寧(ning)）制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司、衛(wei)(wei)材(cai)(cai)(cai)（蘇州）貿易有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司為(wei)業(ye)務支撐的發(fa)展(zhan)模式(shi)。為(wei)適應(ying)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)業(ye)務的迅速發(fa)展(zhan)，2014年11月衛(wei)(wei)材(cai)(cai)(cai)（中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)）藥(yao)(yao)(yao)業(ye)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司注射劑(ji)工(gong)廠竣(jun)工(gong)， 2017年11月新固體制(zhi)(zhi)劑(ji)廠房落成(cheng)，衛(wei)(wei)材(cai)(cai)(cai)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)的產能得到迅速提升。

目前(qian)，總注(zhu)冊(ce)資(zi)本10,854萬美金。已(yi)形成以(yi)神經科學(xue)領(ling)(ling)域、腫瘤(liu)（特藥）領(ling)(ling)域、消化肝病領(ling)(ling)域為主(zhu)要領(ling)(ling)域，拓展(zhan)仿制藥領(ling)(ling)域，多達(da)數十種藥品在中(zhong)國銷售的發展(zhan)規(gui)模(mo)。

未來，蘇(su)州(zhou)工廠(chang)除滿(man)足中國患者臨床用藥的需求(qiu)外，將向亞(ya)洲其它國家和(he)地區同樣提供(gong)高(gao)品(pin)質滿(man)足患者需求(qiu)的產(chan)品(pin)。